Lord, Abbett & Co
QTTB icon

Lord, Abbett & Co’s Q32 Bio QTTB Stock Holding History

Lord, Abbett & Co’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-17,358
Closed -$6.11M – 799
2019
Q2 		$6.11M Sell
17,358
-6,725
-28% -$2.64M 0.02% 637
2019
Q1 		$12M Buy
24,083
+8,650
+56% +$3.87M 0.04% 527
2018
Q4 		$6.21M Sell
15,433
-5,440
-26% -$2.06M 0.02% 618
2018
Q3 		$8.59M Buy
20,873
+3,066
+17% +$1.04M 0.02% 651
2018
Q2 		$6.54M Buy
17,807
+6,696
+60% +$2.4M 0.02% 692
2018
Q1 		$3.74M Buy
+11,111
New +$3.74M 0.01% 763

Other funds holding QTTB

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Lord, Abbett & Co's QTTB Position: Q3 2019 in Review

Lord, Abbett & Co sold out of Q32 Bio (QTTB) in Q3 2019, closing a stake of 17,358 shares — an estimated $6.11M sold.

Lord, Abbett & Co first reported a position in QTTB in Q1 2018 and held it in 6 quarters. The position peaked at $12M in Q1 2019. 80 funds tracked by Wall St. Rank hold QTTB as of Q3 2019.

  • Lord, Abbett & Co reported no remaining Q32 Bio position as of Q3 2019 after selling out during the quarter.
  • Lord, Abbett & Co sold 17,358 Q32 Bio shares in Q3 2019, an estimated $6.11M.
  • Lord, Abbett & Co first reported a position in Q32 Bio in Q1 2018 and held it in 6 quarters.
  • Lord, Abbett & Co's Q32 Bio position peaked at $12M in Q1 2019.
  • 80 funds tracked by Wall St. Rank held Q32 Bio as of Q3 2019.

Based on Lord, Abbett & Co's 13F filing for Q3 2019, filed 14 Nov 2019.